Functional foods as immunomodulators: Tackling the SARS-CoV-2 related cytokine storm–A review

Functional foods as immunomodulators: Tackling the SARS-CoV-2 related cytokine storm–A review

Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus, SARS-CoV-2 continues to strain the health systems globally. Although various therapeutics are being explored for COVID-19 management, such as antiviral drugs, monoclonal antibodies, immunosuppressant drugs, anticoagulants, and the...

Bibliografske podrobnosti
Main Authors:	Harshdeep Kaur, Minni Singh
Format:	Article
Jezik:	English
Izdano:	Elsevier 2023-12-01
Serija:	Food Chemistry Advances
Teme:	COVID-19 SARS-CoV-2 Cytokine storm Functional food Immunomodulators Anti-inflammatory
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2772753X23002289

Podobne knjige/članki

Can natural products modulate cytokine storm in SARS-CoV2 patients?
od: Doha H. Abou Baker
Izdano: (2022-09-01)

Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations
od: Abdusalam Abdullah Alarabei, et al.
Izdano: (2024-03-01)

Immunomodulators and SARS-CoV-2: Management of the Dysregulated Immune Response
od: Chandramouli Mandya Thimmaiah, et al.
Izdano: (2023-04-01)

Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2
od: Heba Salah Abbas, et al.
Izdano: (2023-01-01)

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
od: Alexandra Pum, et al.
Izdano: (2021-01-01)

From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry
od: Darja Kanduc
Izdano: (2021-09-01)

Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak
od: Daniel O. Griffin, et al.
Izdano: (2021-03-01)

Role of epinephrine in attenuating cytokine storm, decreasing ferritin, and inhibiting ferroptosis in SARS-CoV-2
od: Ashraf EL-Molla, et al.
Izdano: (2024-02-01)

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
od: Faheem Hyder Pottoo, et al.
Izdano: (2021-02-01)

Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
od: Abdullahi Rabiu Abubakar, et al.
Izdano: (2022-03-01)

Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
od: Bahareh Hafezi, et al.
Izdano: (2021-07-01)

Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm
od: Si Chen, et al.
Izdano: (2019-06-01)

Immunomodulatory drug therapy for the disease caused by SARS-CoV-2 infection (COVID-19)
od: D. E. Karateev, et al.
Izdano: (2020-09-01)

COVID-19 and Cytokine Storm
od: Mustafa Kurtuluş, et al.
Izdano: (2020-12-01)

Cytokine storm in COVID-19: Potential therapeutics for immunomodulation
od: Md Mohosin Rana
Izdano: (2020-09-01)

Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
od: Hayder M. Al-kuraishy, et al.
Izdano: (2021-11-01)

Clinical Effectiveness of Biological Immunomodulators in SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children: A Systematic Review
od: Ji Young Lee, et al.
Izdano: (2024-09-01)

The critical impacts of cytokine storms in respiratory disorders
od: Shahana Riyaz Tramboo, et al.
Izdano: (2024-05-01)

Host-Based Treatments for Severe COVID-19
od: Lucrezia Mondini, et al.
Izdano: (2023-04-01)

Immunomodulatory Drugs in the Management of SARS-CoV-2
od: Daniel R. Burrage, et al.
Izdano: (2020-08-01)

An adaptable in vitro cytokine release assay (CRA): Susceptibility to cytokine storm in COVID-19 as a model
od: Masih Alam, et al.
Izdano: (2022-01-01)

Intricate relationship between SARS-CoV-2–induced shedding and cytokine storm generation: A signaling inflammatory pathway augmenting COVID-19
od: Moayed Ben Moftah, et al.
Izdano: (2022-03-01)

Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
od: Rowaiye AB, et al.
Izdano: (2021-04-01)

The mechanistic basis linking cytokine storm to thrombosis in COVID-19
od: Adam Wolf, et al.
Izdano: (2022-08-01)

A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection
od: Firoz Ahmed, et al.
Izdano: (2020-12-01)

SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms
od: Marília Inês Móvio, et al.
Izdano: (2024-01-01)

The growth factor/cytokine midkine may participate in cytokine storm and contribute to the pathogenesis of severe acute respiratory syndrome coronavirus 2-infected patients
od: Sema Ketenci, et al.
Izdano: (2021-09-01)

Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges
od: John Hanna, et al.
Izdano: (2021-08-01)

Can alpha‐linolenic acid be a modulator of “cytokine storm,” oxidative stress and immune response in SARS‐CoV‐2 infection?
od: Danila Cianciosi, et al.
Izdano: (2024-01-01)

Pulmonary involvement and cytochemical storm: beyond SARS-CoV-2 pneumoniae
od: Ombretta Para, et al.
Izdano: (2020-12-01)

Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
od: Chaofu Wang, et al.
Izdano: (2020-07-01)

A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug
od: Paul Morgan, et al.
Izdano: (2021-12-01)

MECHANISMS OF CYTOKINE STORM DEVELOPMENT IN COVID-19 AND NEW POTENTIAL TARGETS OF PHARMACOTHERAPY
od: V. I. Petrov, et al.
Izdano: (2021-05-01)

The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes
od: Andrea Piccioni, et al.
Izdano: (2023-09-01)

Olverembatinib inhibits SARS‐CoV‐2‐Omicron variant‐mediated cytokine release in human peripheral blood mononuclear cells
od: Marina Chan, et al.
Izdano: (2022-05-01)

Through DNA sensors and hidden mitochondrial effects of SARS-CoV-2
od: Vitor Pedro Targhetta, et al.
Izdano: (2021-08-01)

Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
od: Basil Mohammed Alomair, et al.
Izdano: (2023-04-01)

Cytokine Response in SARS-CoV-2 Infection in the Elderly
od: Sherwani S, et al.
Izdano: (2020-10-01)

Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
od: Junguo Zhang
Izdano: (2024-07-01)

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
od: Mona A. Mohammed
Izdano: (2023-04-01)